Clinical trial
The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation
NCT00213304 · The Hospital for Sick Children, Other · Completed
Key facts
| NCT number | NCT00213304 |
|---|---|
| Title | The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation |
| Official title | Safety and Immunogenicity of Live Attenuated Oka/Merck Varicella Vaccine in Children Listed to Undergo Solid Organ Transplantation |
| Lead sponsor | The Hospital for Sick Children, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Organ Transplantation, Immunosuppression |
| Intervention type | Biological |
| Interventions | varicella vaccine (VARIVAX) |
| Enrollment | 21 |
| Start date | Jun 1, 1999 |
| Primary completion | Dec 1, 2016 |
| Completion | Dec 1, 2016 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 24, 2021 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: